- Home
- LGL vs TLPH Comparison
LGL vs TLPH Comparison
Compare LGL & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LGL | TLPH |
|---|---|---|
| Founded | 1917 | 2005 |
| Country | United States | United States |
| Employees | 7 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.9M | 37.9M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | LGL | TLPH |
|---|---|---|
| Price | $7.20 | $0.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 4.5K | ★ 211.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,151,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $42.61 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.45 | $0.38 |
| 52 Week High | $9.55 | $1.57 |
Technical Indicators
Market Signals| Indicator | LGL | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 53.07 | 38.42 |
| Support Level | $6.96 | $0.76 |
| Resistance Level | $7.33 | $1.03 |
| Average True Range (ATR) | 0.17 | 0.06 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 44.44 | 11.92 |
Price Performance
Historical ComparisonAbout LGL LGL Group Inc. (The)
LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.